Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2020-05-14 2020-04-03
Drug Identification Number 00532657 00532657
Brand name TEVA-TRIAMTERENE/HCTZ TEVA-TRIAMTERENE/HCTZ
Common or Proper name TEVA-TRIAMTERENE HCTZ 50/25MG TABS TEVA-TRIAMTERENE HCTZ 50/25MG TABS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients TRIAMTERENE HYDROCHLOROTHIAZIDE TRIAMTERENE HYDROCHLOROTHIAZIDE
Strength(s) 50MG 25MG 50MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500's 500's
ATC code C03EA C03EA
ATC description DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-04-01 2020-04-01
Estimated end date Unknown
Actual end date 2020-05-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Item is discontinued Pack size to be discontinued
Health Canada comments